Strata Critical Medical
(NASDAQ) SRTA
Strata Critical Medical Financials at a Glance
Market Cap
$456.00M
Revenue (TTM)
$254.27M
Net Income (TTM)
$46.99M
EPS (TTM)
-$0.12
P/E Ratio
-44.97
Dividend
$0.00
Beta (Volatility)
1.58 (High)
Dividend
$0.00
Beta (Volatility)
1.58 (High)
Price
$5.28
Volume
1,206,798
Open
$5.27
Price
$5.28
Volume
1,206,798
Open
$5.27
Previous Close
$5.28
Daily Range
$5.22 - $5.40
52-Week Range
$3.68 - $6.50
Estimated Earnings Date
Aug 4, 2026
Dividend
$0.00
Beta (Volatility)
1.58 (High)
Price
$5.28
Volume
1,206,798
Open
$5.27
Previous Close
$5.28
Daily Range
$5.22 - $5.40
52-Week Range
$3.68 - $6.50
Estimated Earnings Date
Aug 4, 2026
SRTA News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Strata Critical Medical
Industry
Healthcare Providers and Services
Sector
Health CareEmployees
601
CEO
William A. Heyburn; Melissa M. Tomkiel
Website
www.stratacritical.comHeadquarters
New York, NY 10001, US
SRTA Financials
Key Financial Metrics (TTM)
Gross Margin
21.68%
Operating Margin
-7.85%
Net Income Margin
18.48%
Return on Equity
17.55%
Return on Capital
-7.92%
Return on Assets
14.34%
Earnings Yield
-2.22%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$456.00M
Shares Outstanding
86.53M
Volume
1.21M
Avg. Volume
1.05M
Financials (TTM)
Gross Profit
$55.14M
Operating Income
-$19.96M
EBITDA
-$13.21M
Operating Cash Flow
-$39.66M
Capital Expenditure
-$13.35M
Free Cash Flow
-$53.00M
Cash & ST Invst.
$58.79M
Total Debt
$4.47M
Strata Critical Medical Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$67.38M
+24.1%
Gross Profit
$14.12M
+17.9%
Gross Margin
20.95%
N/A
Market Cap
$456.00M
N/A
Market Cap/Employee
$1.47M
N/A
Employees
310
N/A
Net Income
$2.15M
+161.7%
EBITDA
$86.00K
+104.7%
Quarterly Fundamentals
Total Cash
$58.79M
-51.0%
Total Debt
$4.47M
-50.7%
Accounts Receivable
$39.60M
+79.0%
Inventory
$0.00
N/A
Long Term Debt
$3.48M
-39.0%
Short Term Debt
$987.00K
-70.6%
Return on Assets
14.34%
N/A
Return on Invested Capital
-6.51%
N/A
Free Cash Flow
-$1.93M
+43.2%
Operating Cash Flow
$3.56M
+1545.5%




